This study focuses on the economic impact that private Nova Scotia life sciences firms (including biotechnology firms) have had on the province and nationwide in recent years. The report also examines the significance of public sector R&D in life sciences and the role that public institutions and research may have in fostering private sector activity. Section 3 provides a clear and measurable definition for life sciences. Section 4 describes the task of aggregating key economic indicators to define private sector life sciences firms. In addition, the size of public sector R&D in life sciences and potential links to private sector investment and spin-off firms are explored. Section 5 presents the results of the economic model simulations that calculate direct, indirect and induced impacts of private life science firms on economic indicators, employment and government revenues. Section 6 concludes.
The Economic Contribution of the Nova Scotia Life Sciences Sector
The Economic Contribution of the Nova Scotia Life Sciences Sector
$0.00
This report summarizes the research methods and results of assessing the economic impact of the life sciences sector in Nova Scotia.
Customers Who Downloaded This Also Liked
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
